In support of this, Sokołowski et al., revealed that COX-2 was more expressed in non-secreting hormone pituitary adenomas, while prolactinoma patients showed the lowest expression levels of the COX-2 enzyme [32]. The gene discussed is PTGS2; the disease is pituitary gland adenoma.